Jason Kelly

Jason Kelly

CEO of Ginkgo Bioworks

Jason Kelly co-founded Ginkgo BioWorks in 2008.

Jason earned his PhD from MIT in Biological Engineering in 2008, under professor Drew Endy, and his BS in Chemical Engineering and Biology in 2003. His doctoral research included the development of a widely adopted measurement standard for characterizing transcriptional elements.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Jonathan Shieber
September 19, 2019
TechCrunch
Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion that will give the company the cash to dramatically expand its developer shop for genetic programming. The Boston-based company is one of a handful of U.S.-based early-stage companies that are on the forefront of developing the tools to modify genetic material for [...]
Lauren Johnson
September 16, 2019
Business Insider
Kambr plans to build revenue management software that big airlines can use to monitor how people buy airline flights.
Alexandra Semenova
Invalid Date
DealStreetAsia
Ginkgo's Motif Ingredients, which aims to replicate animal protein for meatless alternatives, is getting $90 million from Breakthrough Energy, others.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.